Today's Research Reports on Trending Tickers: Mylan and Teva Pharmaceutical Industries
NEW YORK, NY / ACCESSWIRE / November 21, 2018 / U.S. markets plunged on Tuesday as FAANG (Facebooks, Amazon, Apple, Netflix and Google) stocks entered into bear market territory, pressuring the tech sector lower. The Dow Jones Industrial Average tumbled 2.21 percent to close at 24,465.64, while the S&P 500 Index decreased 1.82 percent to close at 2,641.89. The Nasdaq Composite Index finished 1.7 percent lower at 6,908.82.
According to Dario Perkins, managing director of global macro at TS Lombard, "Short term, unexpected weakness in the tech sector could have a significant impact on the global economy, adding to what already looks like a soggier macro environment."
"Additional retrenchment in the FAANGs could also undermine the broader US stock market," Perkins added.
The Market Edge Initiates Coverage on:
Mylan N.V.
https://marketedgereport.com/report/MYL/
Teva Pharmaceutical Industries Ltd.
https://marketedgereport.com/report/TEVA/
Mylan's stock moved 1.99% lower Tuesday, to close the day at $33.91. The stock recorded a trading volume of 6,017,754 shares, which was above its three months average volume of 4,751,001 shares. In the last year, Mylan's shares have traded in a range of 30.33 - 47.82. The share price has gained 11.8% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $33.82 is below its 200-day moving average of $36.95. Shares of the company are trading at a Price to Earnings ratio of 32.36. Shares of Mylan have gained roughly 5.28 percent in the past month and are down 19.85 percent year-to-date.
Access The Market Edge's Mylan N.V. Research Report:
https://marketedgereport.com/report/MYL/
On Tuesday, shares of Teva Pharmaceutical Industries recorded a trading volume of 8,310,651 shares, which was below the three months average volume of 11,891,021 shares. The stock ended the day 1.05% lower at $21.77. The share price has fallen 16.14% from its 52 week high with a 52 week trading range of 10.85 - 25.96. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $22.12 is above its 200-day moving average of $21.92. Shares of Teva Pharmaceutical Industries have gained roughly 1.59 percent in the past month and are up 14.88 percent year-to-date.
Access The Market Edge's Teva Pharmaceutical Industries Ltd. Research Report:
https://marketedgereport.com/report/TEVA/
Our Actionable Research on Mylan N.V. (NASDAQ:MYL) and Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) can be downloaded free of charge at The Market Edge.
The Market Edge
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: MarketEdgeReport
